ALFA FinderBSE filing, NSE: ELCIDIN. Summary written from the filing by ALFA Finder's alert engine.
Elcid Investments Ltd: key numbers
- Share price
- ₹98,400.00
- Market cap
- ₹1,968 Cr
- Revenue (annual)
- ₹134.0 Cr
- Net profit (annual)
- ₹108.5 Cr
- P/E (TTM)
- 12.6×Sector 46.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Elcid Investments Ltd
All →Elcid Investments Acquisition Worth ₹1.6 Cr
EL CID Investments will subscribe 160 Series E CCPS of Nexon Omniverse for ₹1.60 Crore. This further investment lifts its fully diluted stake to about 0.60%.
- Value
- ₹1.60 Cr
- Execution
- 30 days (indicative time period for completion)
Elcid Investments Q2 FY27 Results: Net Profit ₹92.1 Cr, Up 190.5% YoY
Elcid Investments Ltd reported revenue from operations of ₹121.2 Cr (+175.5% YoY) and net profit of ₹92.1 Cr (+190.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹92.1 Cr · +190.5% YoY
Elcid Investments Board Meeting Date
Elcid Investments Limited intimated a board meeting on 3 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 25 September to 5 November 2026.
Elcid Investments Other Announcement
EL CID Investments Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Elcid Investments Q1 FY27 Results: Net Profit ₹57.6 Cr, Down 18.4% YoY
Elcid Investments Ltd reported revenue from operations of ₹73.4 Cr (-20.2% YoY) and net profit of ₹57.6 Cr (-18.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹57.6 Cr · -18.4% YoY
Elcid Investments Board Meeting Date
Elcid Investments will hold a board meeting on August 13, 2026, to consider and approve the standalone and consolidated financial results for the quarter ended June 2026.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr